Bleomycin으로 유발한 폐약(肺弱) 태음인 동물 모델에서의 비만에 대한 영향 평가
A Study of the Effect on Obesity in Taeeumin Animal - experimental Model Induced Lung Fibrosis with Bleomycin
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives The objective of this study is to develop a taeeumin animal-experimental model induced lung fibrosis with Bleomycin and evaluate the effect on obesity in this animal-experimental model. Methods The subjects were divided into 3 groups : normal group, high fat diet(HFD) control group, and HFD group administered with bleomycin(n=10 per group). To develop taeeumin animal-experimental model with reduced respiratory metabolism, 8-week-old C57BL/6 mice were administered with 0.03ml solution of bleomycin 1U/ml dissolved in distilled water, intratracheal(IT), once. Then, the HFD control group and the experimental group were fed with high fat diet for 6 weeks. Airway hyperresponsiveness(AHR) to methacholine was measured at the 1st and 3rd week after bleomycin was administered. Food intake and body weight were measured at regular time weekly. After the final experiment, blood was gathered by cardiac puncture for bloodchemical examination and organs(liver, fatty tissue) were remoed, weighted, and mRNA was analyzed. Results and Conclusions Through the experiment, it was found that Bleomycin induced Taeeumin animal-experimental models have leptin resistace. In the experimental group administered with Bleomycin, fatty acid synthesizing gene expression increased and energy metabolizing gene expression decreased. As mRNA expression of adiponectin decreased, it was found that Taeeuim animal-experimental model is susceptible to metabolic syndrome and cardiovascular diseases.
Abstract
Objectives The objective of this study is to develop a taeeumin animal-experimental model induced lung fibrosis with Bleomycin and evaluate the effect on obesity in this animal-experimental model. Methods The subjects were divided into 3 groups : normal group, high fat diet(HFD) control group, and HFD group administered with bleomycin(n=10 per group). To develop taeeumin animal-experimental model with reduced respiratory metabolism, 8-week-old C57BL/6 mice were administered with 0.03ml solution of bleomycin 1U/ml dissolved in distilled water, intratracheal(IT), once. Then, the HFD control group and the experimental group were fed with high fat diet for 6 weeks. Airway hyperresponsiveness(AHR) to methacholine was measured at the 1st and 3rd week after bleomycin was administered. Food intake and body weight were measured at regular time weekly. After the final experiment, blood was gathered by cardiac puncture for bloodchemical examination and organs(liver, fatty tissue) were remoed, weighted, and mRNA was analyzed. Results and Conclusions Through the experiment, it was found that Bleomycin induced Taeeumin animal-experimental models have leptin resistace. In the experimental group administered with Bleomycin, fatty acid synthesizing gene expression increased and energy metabolizing gene expression decreased. As mRNA expression of adiponectin decreased, it was found that Taeeuim animal-experimental model is susceptible to metabolic syndrome and cardiovascular diseases.
참고문헌 (33)
- Lee JM, "Dongeisusebowon", pp.1~32 (1997), Daesungmoonhwasa
- Lee JM, "Dongeisusebowon", pp.36~278 (2003), Yeogang
- Dept. of Sasang Constitutional Medicine. All colleges of Korean med. in Korea, "The revised and enlarged Sasang Constitutional Medicine", pp.131~ (2012), Jipmoondang
- 이준희, "太陰人 病證 分類에 관한 硏究", 사상체질의학회지, 23(1), pp.63~78 (2011), 사상체질의학회
- Moon SH, "A relationship of the obesity and body composition analysis by Sasang constitution", J Oriental Rehab Med, 12(4), pp.1~10 (2002)
- Kim DR, "A study on 4 type constitution and life character of obese patients", J of Const Med, 9(1), pp.303~313 (1997)
- Kim DR, "Clinical Study on the Relationship of Sasang constitution and Obesity", J Sasang Constitut Med, 8(1), pp.319~335 (1996)
- Ryu SM, "Analysis of obesity degree and comparision of weight control program among Sasang constitution", Journal of Korean Oriental Association for Study of Obesity, 5(1), pp.21~29 (2005)
- Adamson IYR, "The pathogenesis of bleomycin induced pulmonary fibrosis in mice", Am J Pathol, 77, pp.185~197 (1974)
- Chandler DB, "Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters", Am J Pathol, 112, pp.981~992 (1996)
- Vanhee D, "Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis", Eur Respir J, 8, pp.834~842 (1995)
- Zhang K, "TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis", J Immunol, 158, pp.954~959 (1997)
- Huaux F, "Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations", Am J Respir Cell Mol Biol, 20, pp.561~572 (1999)
- Lee SG, "The study on the upgrade of QSCCII(II);the study on the re-validity of QSCCII", J Sasang Constitut Med, 15, pp.39~50 (2003)
- 박윤성, "한국인 중년성인에서 사상체질과 폐기능장애, 대사증후군의 연관성 연구", 사상체질의학회지, 25(3), pp.180~194 (2013), 사상체질의학회[DOI]
- Muoio DM, "Peripheral metabolic actions of leptin", Best Pract Res Clin Endocrinol Metab, 16(4), pp.653~666 (2002)
- Galic S, "Adipose tissue as an endocrine organ", Mol Cell Endocrinol, 316, pp.129~139 (2010)
- Unal M, "Serum leptin levels in patients with allergic rhinitis", Otolaryngol Head Neck Surg, 134, pp.331~333 (2006)
- Guler N, "Leptin: does it have any role in childhood asthma?", J Allergy Clin Immunol, 114, pp.254~259 (2004)
- Bruno A, "Does leptin play a cytokine-like role within the airways of COPD patients?", Eur Respir J, 26, pp.398~405 (2005)
- Guven M, "Serum leptin levels in patients with nasal polyposis", J Laryngol Otol, 122, pp.590~592 (2008)
- Lee SM, "Leptin Increases TNF-α Expression and Production through Phospholipase D1 in Raw 264.7 Cells", PLoS One, 9(7), pp.e102373~ (2014)
- Björnholm M, "Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function", J Clin Invest, 117, pp.1354~1360 (2007)
- Lantz KA, "Inhibition of PTP1B by Trodusquemine (MSI‐1436) Causes Fat‐specific Weight Loss in Diet‐induced Obese Mice", Obesity, 18, pp.1517~1523 (2010)
- Steinberg GR, "AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females", J Clin Endocrinol Metab, 89, pp.4575~4580 (2004)
- Cintra DE, "Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity", PLoS One, 7, pp.e30571~ (2012)
- Ozcan L, "Endoplasmic reticulum stress plays a central role in development of leptin resistance", Cell Metab, 9, pp.35~51 (2009)
- Ziemke F, "Adiponectin in insulin resistance: lessons from translational research", Am J Clin Nutr, 91, pp.258S~261S (2010)
- Berg AH, "The adipocyte-secreted protein Acrp30 enhances hepatic insulin action", Nat Med, 7(8), pp.947~953 (2001)
- Matsuzawa Y, "Establishment of a concept of visceral fat syndrome and discovery of adiponectin", Proc Jpn Acad, 86, pp.131~140 (2010)
- Matsuzawa Y, "Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease", Atheroscler Suppl, 6, pp.7~14 (2005)
- Marceau P, "Liver pathology and the metabolic syndrome X in severe obesity", J Clin Endocrinol Metab, 84(5), pp.1513~1517 (1999)
- Brown MS, "The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor", Cell, 89(3), pp.331~340 (1997)